APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine (Plaquenil)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hydroxychloroquine (Plaquenil) Industry Growth and Trends Forecast to 2032

Report ID 174000720131 December 2025120 pages

Choose your research edition.

Industry ResearchHydroxychloroquine (Plaquenil) Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine (Plaquenil) Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine (Plaquenil) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine (Plaquenil) Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine (Plaquenil) Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Hydroxychloroquine (Plaquenil) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxychloroquine (Plaquenil) include Actavis (TEVA ), Advanz Pharma, Aphena Pharma, Apotex Corporation, AvKARE (Amneal Pharmaceuticals), Bristol Laboratories, Cadila Healthcare, Cardinal Health and Cinkate Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hydroxychloroquine (Plaquenil) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydroxychloroquine (Plaquenil) market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxychloroquine (Plaquenil) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxychloroquine (Plaquenil).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydroxychloroquine (Plaquenil) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydroxychloroquine (Plaquenil) Market by Company

Actavis (TEVA )

Advanz Pharma

Aphena Pharma

Apotex Corporation

AvKARE (Amneal Pharmaceuticals)

Bristol Laboratories

Cadila Healthcare

Cardinal Health

Cinkate Corporation

Concordia Healthcare

Covis Pharmaceutical

Hanlim Pharmaceutical

Hikma Pharmaceuticals

Ipca Laboratories

Kyung Poong

Taj Pharmaceuticals

Zydus Cadila

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Hydroxychloroquine (Plaquenil) Segment by Type

100mg

200mg

Other

Hydroxychloroquine (Plaquenil) Segment by Application

COVID-19

Rheumatoid Arthritis

Lupus Erythematosus

Others

Hydroxychloroquine (Plaquenil) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine (Plaquenil) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine (Plaquenil) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine (Plaquenil).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxychloroquine (Plaquenil) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydroxychloroquine (Plaquenil) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg Table 2. Major Company of 200mg Table 3. Major Company of Other Table 4. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 6. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type (2021-2026) Table 9. Global Hydroxychloroquine (Plaquenil) Price by Type (2021-2026) & (US$/Unit) Table 10. Global Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 11. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type (2027-2032) Table 14. Global Hydroxychloroquine (Plaquenil) Price by Type (2027-2032) & (US$/Unit) Table 15. North America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 16. North America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 18. Europe Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 20. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 22. Latin America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 24. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (US$ Million) Table 25. Hydroxychloroquine (Plaquenil) Industry Trends Table 26. Hydroxychloroquine (Plaquenil) Industry Drivers Table 27. Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges Table 28. Hydroxychloroquine (Plaquenil) Industry Restraints Table 29. Global Hydroxychloroquine (Plaquenil) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Company (2021-2026) Table 31. Global Hydroxychloroquine (Plaquenil) Sales by Company (2021-2026) & (M Pcs) Table 32. Global Hydroxychloroquine (Plaquenil) Sales Share by Company (2021-2026) Table 33. Global Hydroxychloroquine (Plaquenil) Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Hydroxychloroquine (Plaquenil) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Hydroxychloroquine (Plaquenil) Major Company Production Sites and Headquarters Table 36. Global Hydroxychloroquine (Plaquenil) Company, Product Type & Application Table 37. Global Hydroxychloroquine (Plaquenil) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Hydroxychloroquine (Plaquenil) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Hydroxychloroquine (Plaquenil) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026) & (M Pcs) Table 42. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Region (2021-2026) Table 45. Global Hydroxychloroquine (Plaquenil) Sales (M Pcs), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Hydroxychloroquine (Plaquenil) Sales by Region (2027-2032) & (M Pcs) Table 47. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Hydroxychloroquine (Plaquenil) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Region (2027-2032) Table 50. Global Hydroxychloroquine (Plaquenil) Sales (M Pcs), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 53. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application (2021-2026) Table 56. Global Hydroxychloroquine (Plaquenil) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 58. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application (2027-2032) Table 61. Global Hydroxychloroquine (Plaquenil) Price by Application (2027-2032) & (US$/Unit) Table 62. North America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 63. North America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 65. Europe Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 67. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 69. Latin America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 71. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (US$ Million) Table 72. Actavis (TEVA ) Company Information Table 73. Actavis (TEVA ) Business Overview Table 74. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio Table 76. Actavis (TEVA ) Recent Development Table 77. Advanz Pharma Company Information Table 78. Advanz Pharma Business Overview Table 79. Advanz Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 81. Advanz Pharma Recent Development Table 82. Aphena Pharma Company Information Table 83. Aphena Pharma Business Overview Table 84. Aphena Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 86. Aphena Pharma Recent Development Table 87. Apotex Corporation Company Information Table 88. Apotex Corporation Business Overview Table 89. Apotex Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 91. Apotex Corporation Recent Development Table 92. AvKARE (Amneal Pharmaceuticals) Company Information Table 93. AvKARE (Amneal Pharmaceuticals) Business Overview Table 94. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio Table 96. AvKARE (Amneal Pharmaceuticals) Recent Development Table 97. Bristol Laboratories Company Information Table 98. Bristol Laboratories Business Overview Table 99. Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 101. Bristol Laboratories Recent Development Table 102. Cadila Healthcare Company Information Table 103. Cadila Healthcare Business Overview Table 104. Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 106. Cadila Healthcare Recent Development Table 107. Cardinal Health Company Information Table 108. Cardinal Health Business Overview Table 109. Cardinal Health Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio Table 111. Cardinal Health Recent Development Table 112. Cinkate Corporation Company Information Table 113. Cinkate Corporation Business Overview Table 114. Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 116. Cinkate Corporation Recent Development Table 117. Concordia Healthcare Company Information Table 118. Concordia Healthcare Business Overview Table 119. Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 121. Concordia Healthcare Recent Development Table 122. Covis Pharmaceutical Company Information Table 123. Covis Pharmaceutical Business Overview Table 124. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 126. Covis Pharmaceutical Recent Development Table 127. Hanlim Pharmaceutical Company Information Table 128. Hanlim Pharmaceutical Business Overview Table 129. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 131. Hanlim Pharmaceutical Recent Development Table 132. Hikma Pharmaceuticals Company Information Table 133. Hikma Pharmaceuticals Business Overview Table 134. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 136. Hikma Pharmaceuticals Recent Development Table 137. Ipca Laboratories Company Information Table 138. Ipca Laboratories Business Overview Table 139. Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 141. Ipca Laboratories Recent Development Table 142. Kyung Poong Company Information Table 143. Kyung Poong Business Overview Table 144. Kyung Poong Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio Table 146. Kyung Poong Recent Development Table 147. Taj Pharmaceuticals Company Information Table 148. Taj Pharmaceuticals Business Overview Table 149. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 151. Taj Pharmaceuticals Recent Development Table 152. Zydus Cadila Company Information Table 153. Zydus Cadila Business Overview Table 154. Zydus Cadila Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio Table 156. Zydus Cadila Recent Development Table 157. Mylan Company Information Table 158. Mylan Business Overview Table 159. Mylan Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Mylan Hydroxychloroquine (Plaquenil) Product Portfolio Table 161. Mylan Recent Development Table 162. Novartis Company Information Table 163. Novartis Business Overview Table 164. Novartis Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Novartis Hydroxychloroquine (Plaquenil) Product Portfolio Table 166. Novartis Recent Development Table 167. Sanofi Company Information Table 168. Sanofi Business Overview Table 169. Sanofi Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio Table 171. Sanofi Recent Development Table 172. Shanghai Pharmaceuticals Holding Company Information Table 173. Shanghai Pharmaceuticals Holding Business Overview Table 174. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio Table 176. Shanghai Pharmaceuticals Holding Recent Development Table 177. Sun Pharma Company Information Table 178. Sun Pharma Business Overview Table 179. Sun Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 181. Sun Pharma Recent Development Table 182. North America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 183. North America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 184. North America Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2026) Table 185. North America Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032) & (M Pcs) Table 186. North America Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Country (2027-2032) Table 187. North America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. North America Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026) & (US$ Million) Table 189. North America Hydroxychloroquine (Plaquenil) Market Share by Country (2021-2026) Table 190. North America Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. North America Hydroxychloroquine (Plaquenil) Market Share Forecast by Country (2027-2032) Table 192. Europe Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 193. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 194. Europe Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2026) Table 195. Europe Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032) & (M Pcs) Table 196. Europe Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Country (2027-2032) Table 197. Europe Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Europe Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026) & (US$ Million) Table 199. Europe Hydroxychloroquine (Plaquenil) Market Share by Country (2021-2026) Table 200. Europe Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Europe Hydroxychloroquine (Plaquenil) Market Share Forecast by Country (2027-2032) Table 202. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 203. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 204. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2026) Table 205. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032) & (M Pcs) Table 206. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Country (2027-2032) Table 207. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026) & (US$ Million) Table 209. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Share by Country (2021-2026) Table 210. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Share Forecast by Country (2027-2032) Table 212. Latin America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 213. Latin America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 214. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2026) Table 215. Latin America Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032) & (M Pcs) Table 216. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Country (2027-2032) Table 217. Latin America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Latin America Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026) & (US$ Million) Table 219. Latin America Hydroxychloroquine (Plaquenil) Market Share by Country (2021-2026) Table 220. Latin America Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Latin America Hydroxychloroquine (Plaquenil) Market Share Forecast by Country (2027-2032) Table 222. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 223. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 224. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2026) Table 225. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032) & (M Pcs) Table 226. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Country (2027-2032) Table 227. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026) & (US$ Million) Table 229. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Share by Country (2021-2026) Table 230. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Share Forecast by Country (2027-2032) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. Hydroxychloroquine (Plaquenil) Distributors List Table 235. Hydroxychloroquine (Plaquenil) Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. Hydroxychloroquine (Plaquenil) Image Figure 2. Global Hydroxychloroquine (Plaquenil) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine (Plaquenil) Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxychloroquine (Plaquenil) Sales (2021-2032) & (M Pcs) Figure 5. 100mg Image Figure 6. Global 100mg Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. 200mg Image Figure 8. Global 200mg Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Global Hydroxychloroquine (Plaquenil) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Hydroxychloroquine (Plaquenil) Market Share by Type 2025 VS 2032 Figure 13. North America Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type in 2025 Figure 14. North America Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type in 2025 Figure 15. Europe Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Hydroxychloroquine (Plaquenil) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. COVID-19 Image Figure 26. Global COVID-19 Sales YoY Growth (2021-2032) & (M Pcs) Figure 27. Rheumatoid Arthritis Image Figure 28. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (M Pcs) Figure 29. Lupus Erythematosus Image Figure 30. Global Lupus Erythematosus Sales YoY Growth (2021-2032) & (M Pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (M Pcs) Figure 33. Global Hydroxychloroquine (Plaquenil) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hydroxychloroquine (Plaquenil) Market Share by Application 2025 VS 2032 Figure 35. North America Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application in 2025 Figure 36. North America Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application in 2025 Figure 37. Europe Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application in 2025 Figure 38. Europe Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application in 2025 Figure 41. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application in 2025 Figure 45. North America Hydroxychloroquine (Plaquenil) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 46. North America Hydroxychloroquine (Plaquenil) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Hydroxychloroquine (Plaquenil) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Hydroxychloroquine (Plaquenil) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hydroxychloroquine (Plaquenil) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 50. Europe Hydroxychloroquine (Plaquenil) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hydroxychloroquine (Plaquenil) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Hydroxychloroquine (Plaquenil) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 54. Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Hydroxychloroquine (Plaquenil) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hydroxychloroquine (Plaquenil) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 58. Latin America Hydroxychloroquine (Plaquenil) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hydroxychloroquine (Plaquenil) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Hydroxychloroquine (Plaquenil) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 62. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Hydroxychloroquine (Plaquenil) Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hydroxychloroquine (Plaquenil) Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Hydroxychloroquine (Plaquenil) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 200mg
  • Other
Applications
  • COVID-19
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Others
Companies covered
  • Actavis (TEVA )
  • Advanz Pharma
  • Aphena Pharma
  • Apotex Corporation
  • AvKARE (Amneal Pharmaceuticals)
  • Bristol Laboratories
  • Cadila Healthcare
  • Cardinal Health
  • Cinkate Corporation
  • Concordia Healthcare
  • Covis Pharmaceutical
  • Hanlim Pharmaceutical
  • Hikma Pharmaceuticals
  • Ipca Laboratories
  • Kyung Poong
  • Taj Pharmaceuticals
  • Zydus Cadila
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxychloroquine (Plaquenil) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydroxychloroquine (Plaquenil) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydroxychloroquine (Plaquenil) Market by Type
  6. 1.3.1 100mg
  7. 1.3.2 200mg
  8. 1.3.3 Other
  9. 1.4 Global Hydroxychloroquine (Plaquenil) Market Size by Type
  10. 1.4.1 Global Hydroxychloroquine (Plaquenil) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Hydroxychloroquine (Plaquenil) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Hydroxychloroquine (Plaquenil) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Hydroxychloroquine (Plaquenil) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Hydroxychloroquine (Plaquenil) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Hydroxychloroquine (Plaquenil) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydroxychloroquine (Plaquenil) Industry Trends
  2. 2.2 Hydroxychloroquine (Plaquenil) Industry Drivers
  3. 2.3 Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine (Plaquenil) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydroxychloroquine (Plaquenil) Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydroxychloroquine (Plaquenil) Sales (2021-2026)
  3. 3.3 Global Top Players by Hydroxychloroquine (Plaquenil) Price (2021-2026)
  4. 3.4 Global Hydroxychloroquine (Plaquenil) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxychloroquine (Plaquenil) Major Company Production Sites & Headquarters
  6. 3.6 Global Hydroxychloroquine (Plaquenil) Company, Product Type & Application
  7. 3.7 Global Hydroxychloroquine (Plaquenil) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxychloroquine (Plaquenil) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxychloroquine (Plaquenil) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxychloroquine (Plaquenil) Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine (Plaquenil) Regional Status and Outlook
  1. 4.1 Global Hydroxychloroquine (Plaquenil) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydroxychloroquine (Plaquenil) Historic Market Size by Region
  3. 4.2.1 Global Hydroxychloroquine (Plaquenil) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydroxychloroquine (Plaquenil) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydroxychloroquine (Plaquenil) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydroxychloroquine (Plaquenil) Forecasted Market Size by Region
  7. 4.3.1 Global Hydroxychloroquine (Plaquenil) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydroxychloroquine (Plaquenil) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydroxychloroquine (Plaquenil) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxychloroquine (Plaquenil) by Application
  1. 5.1 Hydroxychloroquine (Plaquenil) Market by Application
  2. 5.1.1 COVID-19
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Lupus Erythematosus
  5. 5.1.4 Others
  6. 5.2 Global Hydroxychloroquine (Plaquenil) Market Size by Application
  7. 5.2.1 Global Hydroxychloroquine (Plaquenil) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Hydroxychloroquine (Plaquenil) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Hydroxychloroquine (Plaquenil) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Hydroxychloroquine (Plaquenil) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Hydroxychloroquine (Plaquenil) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Hydroxychloroquine (Plaquenil) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actavis (TEVA )
  2. 6.1.1 Actavis (TEVA ) Company Information
  3. 6.1.2 Actavis (TEVA ) Business Overview
  4. 6.1.3 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio
  6. 6.1.5 Actavis (TEVA ) Recent Developments
  7. 6.2 Advanz Pharma
  8. 6.2.1 Advanz Pharma Company Information
  9. 6.2.2 Advanz Pharma Business Overview
  10. 6.2.3 Advanz Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  12. 6.2.5 Advanz Pharma Recent Developments
  13. 6.3 Aphena Pharma
  14. 6.3.1 Aphena Pharma Company Information
  15. 6.3.2 Aphena Pharma Business Overview
  16. 6.3.3 Aphena Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  18. 6.3.5 Aphena Pharma Recent Developments
  19. 6.4 Apotex Corporation
  20. 6.4.1 Apotex Corporation Company Information
  21. 6.4.2 Apotex Corporation Business Overview
  22. 6.4.3 Apotex Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  24. 6.4.5 Apotex Corporation Recent Developments
  25. 6.5 AvKARE (Amneal Pharmaceuticals)
  26. 6.5.1 AvKARE (Amneal Pharmaceuticals) Company Information
  27. 6.5.2 AvKARE (Amneal Pharmaceuticals) Business Overview
  28. 6.5.3 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio
  30. 6.5.5 AvKARE (Amneal Pharmaceuticals) Recent Developments
  31. 6.6 Bristol Laboratories
  32. 6.6.1 Bristol Laboratories Company Information
  33. 6.6.2 Bristol Laboratories Business Overview
  34. 6.6.3 Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  36. 6.6.5 Bristol Laboratories Recent Developments
  37. 6.7 Cadila Healthcare
  38. 6.7.1 Cadila Healthcare Company Information
  39. 6.7.2 Cadila Healthcare Business Overview
  40. 6.7.3 Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  42. 6.7.5 Cadila Healthcare Recent Developments
  43. 6.8 Cardinal Health
  44. 6.8.1 Cardinal Health Company Information
  45. 6.8.2 Cardinal Health Business Overview
  46. 6.8.3 Cardinal Health Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio
  48. 6.8.5 Cardinal Health Recent Developments
  49. 6.9 Cinkate Corporation
  50. 6.9.1 Cinkate Corporation Company Information
  51. 6.9.2 Cinkate Corporation Business Overview
  52. 6.9.3 Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  54. 6.9.5 Cinkate Corporation Recent Developments
  55. 6.10 Concordia Healthcare
  56. 6.10.1 Concordia Healthcare Company Information
  57. 6.10.2 Concordia Healthcare Business Overview
  58. 6.10.3 Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  60. 6.10.5 Concordia Healthcare Recent Developments
  61. 6.11 Covis Pharmaceutical
  62. 6.11.1 Covis Pharmaceutical Company Information
  63. 6.11.2 Covis Pharmaceutical Business Overview
  64. 6.11.3 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  66. 6.11.5 Covis Pharmaceutical Recent Developments
  67. 6.12 Hanlim Pharmaceutical
  68. 6.12.1 Hanlim Pharmaceutical Company Information
  69. 6.12.2 Hanlim Pharmaceutical Business Overview
  70. 6.12.3 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  72. 6.12.5 Hanlim Pharmaceutical Recent Developments
  73. 6.13 Hikma Pharmaceuticals
  74. 6.13.1 Hikma Pharmaceuticals Company Information
  75. 6.13.2 Hikma Pharmaceuticals Business Overview
  76. 6.13.3 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  78. 6.13.5 Hikma Pharmaceuticals Recent Developments
  79. 6.14 Ipca Laboratories
  80. 6.14.1 Ipca Laboratories Company Information
  81. 6.14.2 Ipca Laboratories Business Overview
  82. 6.14.3 Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  84. 6.14.5 Ipca Laboratories Recent Developments
  85. 6.15 Kyung Poong
  86. 6.15.1 Kyung Poong Company Information
  87. 6.15.2 Kyung Poong Business Overview
  88. 6.15.3 Kyung Poong Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio
  90. 6.15.5 Kyung Poong Recent Developments
  91. 6.16 Taj Pharmaceuticals
  92. 6.16.1 Taj Pharmaceuticals Company Information
  93. 6.16.2 Taj Pharmaceuticals Business Overview
  94. 6.16.3 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  96. 6.16.5 Taj Pharmaceuticals Recent Developments
  97. 6.17 Zydus Cadila
  98. 6.17.1 Zydus Cadila Company Information
  99. 6.17.2 Zydus Cadila Business Overview
  100. 6.17.3 Zydus Cadila Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio
  102. 6.17.5 Zydus Cadila Recent Developments
  103. 6.18 Mylan
  104. 6.18.1 Mylan Company Information
  105. 6.18.2 Mylan Business Overview
  106. 6.18.3 Mylan Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Mylan Hydroxychloroquine (Plaquenil) Product Portfolio
  108. 6.18.5 Mylan Recent Developments
  109. 6.19 Novartis
  110. 6.19.1 Novartis Company Information
  111. 6.19.2 Novartis Business Overview
  112. 6.19.3 Novartis Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Novartis Hydroxychloroquine (Plaquenil) Product Portfolio
  114. 6.19.5 Novartis Recent Developments
  115. 6.20 Sanofi
  116. 6.20.1 Sanofi Company Information
  117. 6.20.2 Sanofi Business Overview
  118. 6.20.3 Sanofi Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio
  120. 6.20.5 Sanofi Recent Developments
  121. 6.21 Shanghai Pharmaceuticals Holding
  122. 6.21.1 Shanghai Pharmaceuticals Holding Company Information
  123. 6.21.2 Shanghai Pharmaceuticals Holding Business Overview
  124. 6.21.3 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio
  126. 6.21.5 Shanghai Pharmaceuticals Holding Recent Developments
  127. 6.22 Sun Pharma
  128. 6.22.1 Sun Pharma Company Information
  129. 6.22.2 Sun Pharma Business Overview
  130. 6.22.3 Sun Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  132. 6.22.5 Sun Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Hydroxychloroquine (Plaquenil) Sales by Country
  2. 7.1.1 North America Hydroxychloroquine (Plaquenil) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026)
  4. 7.1.3 North America Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydroxychloroquine (Plaquenil) Market Size by Country
  6. 7.2.1 North America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydroxychloroquine (Plaquenil) Sales by Country
  2. 8.1.1 Europe Hydroxychloroquine (Plaquenil) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydroxychloroquine (Plaquenil) Market Size by Country
  6. 8.2.1 Europe Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Country
  2. 9.1.1 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size by Country
  6. 9.2.1 Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydroxychloroquine (Plaquenil) Sales by Country
  2. 10.1.1 South America Hydroxychloroquine (Plaquenil) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026)
  4. 10.1.3 South America Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydroxychloroquine (Plaquenil) Market Size by Country
  6. 10.2.1 South America Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country
  2. 11.1.1 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size by Country
  6. 11.2.1 Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydroxychloroquine (Plaquenil) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydroxychloroquine (Plaquenil) Value Chain Analysis
  2. 12.1.1 Hydroxychloroquine (Plaquenil) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydroxychloroquine (Plaquenil) Production Mode & Process
  7. 12.2 Hydroxychloroquine (Plaquenil) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydroxychloroquine (Plaquenil) Distributors
  10. 12.2.3 Hydroxychloroquine (Plaquenil) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst